{"id":"gcflu-quadrivalent-inj-vaccine","safety":{"commonSideEffects":[{"rate":"10–30","effect":"Injection site pain, redness, or swelling"},{"rate":"5–15","effect":"Myalgia (muscle pain)"},{"rate":"5–10","effect":"Headache"},{"rate":"5–10","effect":"Fatigue"},{"rate":"1–5","effect":"Low-grade fever"}]},"_chembl":{"chemblId":"CHEMBL2108573","moleculeType":"Vaccine component"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The vaccine contains inactivated (killed) virus particles or viral antigens from four influenza strains (typically two A subtypes and two B lineages). Upon injection, these antigens trigger both humoral and cellular immune responses, leading to the production of strain-specific antibodies and memory B cells that provide protection against infection with matching circulating influenza viruses.","oneSentence":"GCFLU Quadrivalent is an inactivated influenza vaccine that stimulates the immune system to produce antibodies against four strains of influenza virus.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:13:44.868Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Seasonal influenza prevention in adults and children"}]},"trialDetails":[{"nctId":"NCT03657719","phase":"PHASE2","title":"A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Elderly Healthy Subjects","status":"COMPLETED","sponsor":"Green Cross Corporation","startDate":"2018-10-01","conditions":"Influenza, Human","enrollment":105},{"nctId":"NCT03357263","phase":"PHASE1","title":"A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Healthy Adults","status":"COMPLETED","sponsor":"Green Cross Corporation","startDate":"2017-11-20","conditions":"Influenza, Human","enrollment":40},{"nctId":"NCT03285997","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of GC3110A in Healthy Infants From 6 Months to 35 Months of Age","status":"UNKNOWN","sponsor":"Green Cross Corporation","startDate":"2017-09-30","conditions":"Influenza Vaccine","enrollment":260},{"nctId":"NCT02915809","phase":"PHASE3","title":"A Study to Evaluate Efficacy and Safety of GC3110B in Healthy Adults","status":"UNKNOWN","sponsor":"Green Cross Corporation","startDate":"2016-10","conditions":"Influenza, Human","enrollment":414}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["GCFLU Quadrivalent Inj."],"phase":"phase_3","status":"active","brandName":"GCFLU Quadrivalent Inj. vaccine","genericName":"GCFLU Quadrivalent Inj. vaccine","companyName":"Green Cross Corporation","companyId":"green-cross-corporation","modality":"Biologic","firstApprovalDate":"","aiSummary":"GCFLU Quadrivalent is an inactivated influenza vaccine that stimulates the immune system to produce antibodies against four strains of influenza virus. Used for Seasonal influenza prevention in adults and children.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}